Have you ever watched a stock everyone calls “safe” keep climbing until the safety starts to look expensive? That is the uneasy feeling around Coca-Cola right now. The brand is still iconic. The cash still shows up. The dividend streak is still the kind of record investors brag about at dinner. And yet the multiple, the limited upside in published targets, and a messy tax fight make the easy story a little less easy. I’ve found that defensive investing often fails not because the business is weak, but because the price already baked in the comfort.
Why Defensive Appeal Is Getting A Reality Check
When headlines pile up around conflict, sticky prices, higher policy rates, and the possibility that the artificial intelligence trade cools off, money looks for shelter. Healthcare, utilities, and consumer staples usually get the first call. People still buy medicine, keep the lights on, and grab groceries. Inside those groups, investors tend to crowd the household names: huge market share, thick cash flow, pricing power, a brand that survives fashion cycles.
Few names tick those boxes as neatly as Coca-Cola. Founded in the nineteenth century, listed for more than a century, it has lifted its dividend for 64 consecutive years and has sat in the Dow since 1987. Shares have compounded dramatically over that long membership. It still commands about half of the global carbonated soft drink market. On paper, that is the definition of a fortress.
The latest quarter did not spoil the legend. Organic sales rose about 6 percent against a much softer consensus. Comparable operating margin expanded. Comparable earnings per share beat expectations. Management raised full-year guidance, including free cash flow near $12.4 billion. One analyst called it among the cleanest beats in staples this season. Hard to argue with the operating print.
The Premium That Makes The Safety Feel Crowded
Here is the rub. Year to date the stock has been one of the stronger Dow names, up roughly 29 percent. Street sentiment is warm: a heavy tilt toward buys, almost no underperform ratings. The average target, though, sits only about 6 percent above the market price. That is not a disaster. It is also not a gift.
One major firm put Coca-Cola on a high-conviction consumer list even while admitting it sat at the bottom of that list for expected upside. Peers on the same slate carried much fatter implied gains. Another note argued the stock trades about 32 percent above its typical premium to the group, versus a historical gap closer to 5 percent. The bull case is that better fundamentals justify the stretch and could even support more multiple expansion. A more cautious take says the premium is earned on growth quality, but the room to push the multiple higher from here looks thin.
At around $89, the next-twelve-months earnings multiple is near 26 times. That compares with an index multiple closer to 19 times. Paying a large gap for insulation makes more sense when the cycle is cracking. It looks less obvious when quarterly growth is expected to run hot. In my experience, investors sometimes treat staples as all-weather insurance and forget that insurance itself has a price.
A fortress brand can still be a crowded trade if the valuation already assumes the fortress never has a bad year.
Look at the price-to-earnings-to-growth ratio. A reading under 1 often signals you are not overpaying for expected earnings growth. Above 2 starts to feel rich. Coca-Cola’s expected PEG for 2026 sits around 3.4. That single number does not end the debate. It does force a slower walk around the stock.
The dividend remains reliable, yet the yield near 2.4 percent is a hair below the average consumer staple. You are not being paid extra income to wait out a possible de-rating. You are mostly paid in brand comfort.
The Tax Case Investors Keep Underweighting
Then there is the company-specific cloud. A transfer pricing dispute over how profits are allocated between foreign units and the U.S. parent has created a potential hit that some estimates put as high as $20 billion. After a loss in tax court, the company is appealing. It has already deposited about $6 billion with the tax authority and could face another $14 billion if the appeal fails. Only a sliver, about $512 million, has been reserved. That gap between cash already posted, possible remaining payment, and accounting reserve is not a rounding error.
A bear sketch from one large-bank analyst put a downside case near $54. The story there is ugly but coherent: weaker global demand, volume leverage working the wrong way, about 200 basis points of operating margin pressure versus a base case, full payment of a huge tax bill, a higher ongoing tax rate, and a multiple compressed toward 15 times later-cycle earnings. You do not have to adopt that case. You should at least price the possibility that “defensive” does not mean “no idiosyncratic risk.”
History offers a blunt reminder. In 1974 the shares fell about 57 percent after the oil shock of 1973. Inflation and rates jumped. Consumers pulled back. Coca-Cola was then part of the so-called Nifty Fifty, the cluster of blue-chip growth names treated as almost unbreakable. Multiples collapsed anyway. Quality did not immunize owners against a re-rating when the starting price was heroic.
Pepsi As The Diversified, Higher-Yield Defense
If the goal is still beverages and snacks rather than a leap into an unrelated sector, PepsiCo is the first place many value-minded investors look. The cola lineage is almost as old. The structural twist came in 1965 with the Frito-Lay combination. Today roughly 42 percent of sales sit in drinks and 58 percent in food. That mix is not automatically better in every quarter. It is different, and difference matters when one category hits a wall.
Pepsi is trying to reset. An activist built a sizable stake and pushed a plan to slim the U.S. lineup by about 20 percent and take a more aggressive stance on price. Management has sounded constructive. Organic revenue grew about 2.5 percent in the first half. Organic volume posted its best pace since 2022. That is progress. The share price has not celebrated it. Over the past year the stock is down more than 8 percent.
Valuation is the contrast that jumps off the page. A next-twelve-months multiple near 15 times sits well below a five-year average closer to 21 times. The dividend yield near 4.6 percent starts to look competitive with government paper for investors who want income without abandoning equities. Analysts are less giddy than they are on Coca-Cola: more holds, fewer buys. Oddly, the average target still implies more than 18 percent upside, which is a better advertised reward than the Coke setup.
The next earnings date will be a live test. One cautious note expects international strength to keep covering softness in North America and looks for the company to reaffirm the year outlook while investors hunt for proof that U.S. snacks and drinks can stabilize. A more constructive view points to margin-helpful international growth and “breadcrumbs” of better U.S. volume later in the year, even if the rebound is slower than first hoped.
- Lower multiple than the category leader
- Higher cash yield for patient holders
- Food-and-beverage mix that is not a single-category bet
- Turnaround risk that is visible, not hidden
Perhaps the most interesting aspect is psychological. Crowds love the winner that already won. Pepsi asks you to underwrite a repair job. That is less comfortable. It can also be cheaper.
Keurig Dr Pepper And The Spinoff Discount
Keurig Dr Pepper trades even cheaper on a next-twelve-months earnings multiple, around 13 times. Last year it outlined a plan to buy a large European coffee-and-tea group for about $18 billion, fold that business into its coffee assets, and later separate the combined coffee platform. Brands in that future coffee company would include well-known specialty and pod names. Management has said early integration feels constructive and has pointed to roughly $400 million of cost saves over three years.
On the soda side, the zero-sugar Dr Pepper line grew about 30 percent year over year in the latest reported quarter and is now described as the second-largest zero-sugar brand in the market, with more than $1 billion in retail sales. That is not a footnote. Flavor and better-for-you reformulation still move the register in a category people treat as mature.
The 2027 spin timetable makes some holders nervous. Complexity does that. One research note argued apathy has set in and the multiple sits at a record low versus history. Split the pieces and a scaled non-alcoholic beverage platform might deserve something above 20 times earnings while a global coffee business might live closer to 10 times. Blend those views and mid-teens starts to look like a floor, with room if confidence rebuilds. The average published target implies about 13 percent upside, with a constructive ratings mix and no underperform calls in the tally cited.
I’ve sat through enough spin stories to know they can drag. I’ve also seen them unlock a cleaner sum-of-the-parts once the market stops treating two businesses as one muddy average. If you want defense with a catalyst, this is messier than Coca-Cola and, for that reason, less loved.
| Name | Style of defense | Valuation snapshot | Income profile |
| Coca-Cola | Brand fortress, high quality | Rich multiple, thin published upside | Steady dividend, modest yield |
| PepsiCo | Food plus drinks, turnaround | Discount to its own history | Higher yield, income-friendly |
| Keurig Dr Pepper | Soda plus coffee split story | Lower multiple, spin complexity | Value first, catalyst later |
When The Bond Is The Defensive Product
There is another way to stay close to Coca-Cola without owning the equity multiple. Own the debt. The credit rating sits in high-grade territory with a stable outlook. Existing notes in the three-to-seven-year window have recently yielded only about 10 to 20 basis points over Treasuries. That is tight. It is also a reminder that the market still treats the company as a premier borrower.
After the rate shock of the early 2020s, starting yields on quality bonds finally offer a cushion that near-zero coupons never did. One macro strategist put it plainly: low starting yields gave no protection in the last bond bear market, and that painful stretch is likely behind the worst of the negative-return era. I would not call any bond risk-free. I would say the math of defense changed when cash and intermediate paper started paying something real again.
For an investor who wants Coca-Cola’s balance sheet more than Coca-Cola’s multiple, the notes can be the cleaner expression. You give up equity upside. You also give up a lot of the valuation argument and some of the tax-case drama that hits residual owners first.
How To Think About Risk When Everyone Wants Shelter
Defensive stocks are not a personality type. They are a cash-flow profile. Stable demand, repeat purchases, pricing power, and dividends that do not vanish in a slump. That profile still matters. The mistake is treating the profile as a substitute for price discipline.
- Start with the business quality, not the slogan.
- Check whether the multiple already assumes a perfect landing.
- Compare yield and growth so you know what you are being paid to wait.
- Map company-specific landmines, not only macro weather.
- Ask whether a peer or a bond expresses the same theme with less hope priced in.
Coca-Cola still does the first step brilliantly. Steps two through five are where the current debate lives. A 26 times forward multiple, a PEG above 3, limited implied upside, and a large unresolved tax item do not erase the brand. They change the payoff.
Pepsi asks you to believe a reset in North America can stick while international carries the print. Keurig Dr Pepper asks you to live with a multi-year separation and still underwrite soda momentum. Bonds ask you to accept coupon income and credit spread instead of earnings surprises. None of those is a free lunch. Each is a different mix of valuation, income, growth optionality, and headache.
A Practical Framework For Building A Defensive Sleeve
If I were sketching a sleeve rather than picking a single hero stock, I would split the job. Keep a high-quality compounder if the position is already sized and the time horizon is measured in decades, not quarters. Add a cheaper operator with a higher yield if income and mean reversion do more of the work. Use a special-situation staple if you can tolerate a calendar that stretches into a spin year. Park some dry powder in short and intermediate high-grade paper so the sleeve still throws off cash if equities wobble.
That is not a formula. Markets do not run on formulas for long. It is a way to stop treating “defensive” as a single ticker. Consumer staples as a group can look sleepy until you notice how often leadership rotates inside the group. The brand that feels inevitable can lag for years while a less loved cousin quietly compounds through buybacks and a fatter check in the mail.
Defense checklist in plain language: Quality of demand Price you pay for that quality Cash you collect while you wait Risks that do not show up in the slogan Other ways to own the same idea
Notice what is missing from that list: recency of outperformance. A stock can be the sixth-best Dow name this year and still be a poorer forward bet than a laggard with a lower multiple and a higher yield. Past performance is comforting. Forward math is ruder and more useful.
What A Soft Patch Would Actually Stress
In a mild slowdown, premium staples often hold up because shoppers trade down inside the aisle rather than leaving the aisle. That helps Coca-Cola more than a luxury name. In a sharper squeeze, volume can still slip, promotions can creep back, and retailers can get tougher. The 1974 episode is extreme. It is also a reminder that “people always drink soda” did not stop a brutal multiple reset when inflation and rates rewrote discount rates.
Pepsi’s food exposure can cut both ways. Snacks can be resilient little treats when households cut bigger trips. They can also face private-label pressure when budgets get ugly. Keurig’s at-home coffee system leans on installed hardware and recurring pods, which is a different defensive shape than a fountain-and-bottle network. Bonds care first about coverage ratios and refinancing, not same-store sentiment in a convenience channel.
So the question is not “which brand survives.” Survival is the easy part for these three. The question is which combination of price, yield, and residual risk leaves you sleeping through a noisy year.
Safety is not a logo. Safety is what remains after you subtract the price you paid and the risks the crowd is bored of discussing.
Valuation Language Without The Jargon Fog
A forward price-to-earnings multiple is simply how many years of expected earnings the market is willing to prepay. Twenty-six times is a long prepayment. Fifteen times is a shorter one. Thirteen times is shorter still. PEG tries to adjust that prepayment for growth. When growth is mid-single digit and the multiple is mid-20s, the ratio inflates. That is not a moral judgment. It is arithmetic.
Dividend yield is the cash you collect if the board does not blink. A 2.4 percent yield on a fortress is fine if the multiple also expands. It is less fine if the multiple compresses toward the group average. A 4.6 percent yield gives the laggard a head start even if the rerating takes time. That head start is why income investors can afford to be early and a little lonely.
Credit spread is the extra yield a bondholder demands over a government note. Ten to twenty basis points over Treasuries for three-to-seven-year Coca-Cola paper is a compliment from the credit market. It also means most of the defensive work in that instrument now comes from the Treasury yield itself, not from a fat corporate extra.
Behavioral Traps That Show Up In “Safe” Names
Familiarity bias is the quiet killer. You know the logo. You drank the product as a kid. The chart has gone up for a long time. That warmth can substitute for work. Recency bias piles on when a stock has already been a winner this year. Narrative bias finishes the job: “quality always wins” is a sentence that survives until it does not.
I’ve caught myself doing this. A clean quarter arrives, guidance ticks higher, and the brain files the name under “solved.” Then you look at the target sheet and realize the street’s own numbers do not leave much room. That pause is useful. It does not require you to become a perma-bear. It requires you to ask what you own if the multiple simply stops expanding.
Another trap is treating an activist situation as either magic or poison. Pepsi’s reset could work. It could also take longer than the calendar implied in optimistic notes. Special situations are not automatically cheap. They are only cheap if the base business still prints cash while the story gets rewritten.
Putting The Pieces Together Without Pretending Certainty
Coca-Cola remains a high-quality compounder with a rare dividend record and a global fountain-and-package machine that is hard to copy. That sentence can be true at the same time as this one: at today’s multiple, with modest implied upside and a live tax appeal, the stock is no longer the obvious default hideout.
Pepsi offers a lower starting valuation, a fatter yield, and a more diversified profit pool, with the trade-off of a turnaround that still needs proof in North America. Keurig Dr Pepper offers an even lower multiple and a structural catalyst, with the trade-off of integration noise and a multi-year wait. Coca-Cola’s own bonds offer credit quality and a simpler defensive posture now that starting yields are no longer a rounding error.
None of this is a recommendation to buy or sell any security. Personal balance sheets, tax lots, time horizons, and sleep patterns differ. The useful work is comparative. If you want defense, compare the price of defense. If you want income, compare the check. If you want fewer company-specific surprises, compare the footnotes, not just the brand campaign.
Markets will keep swinging between “risk on” and “please hide.” The names that feel safest at the moment of hiding are often the names that already ran. That does not make them bad businesses. It makes them incomplete answers. The more interesting sleeve is usually a mix: one compounder you already understand, one cheaper operator with a real yield, one messy catalyst if you can stand the wait, and some high-grade paper so the whole construction still pays you while the argument plays out.
That is a less romantic story than “own the greatest brand and forget about it.” It is also closer to how defense actually works when valuations get stretched and the easy trade is already crowded. The next chapter in this group will not be written by nostalgia. It will be written by multiples, cash yields, and whether those tax and turnaround footnotes stay footnotes or become the main plot.
